Corporate news


Grifols improves safety of transfusions with its ID CORE XT diagnostic kit The molecular diagnostic kit available in the United States since last year has obtained CE marking. The diagnostic kit offers greater donor–patient compatibility by testing 37 antigens of 10 blood groups in less than 4 hours on the basis of a DNA sample. According to WHO data, 5% of the world's population carry genes for hereditary blood disorders, and each year over 300,000 children are born suffering from these conditions.
+ info

Grifols launches a continuing education program for transfusion medicine professionals in the United States The program is designed to update knowledge and share advances in the field of transfusion safety.
+ info

Highlights

Manufacturing

Manufacturing
We are a solid company with an international dimension.

Corporate Commitment

People
We contribute to improving people's health and wellbeing by offering safe, high quality products produced using the latest environmentally friendly technology.

New transfusion medicine solutions

Grifols is committed to helping you work efficiently to deliver blood that is safe and compatible for patients. + info

 

get to know us better